The therapeutic efficacy of the IGF-Trap has recently been demonstrated in breast carcinoma, high-grade pediatric gliomas, triple-negative breast cancer, and pancreatic ductal adenocarcinoma using in vitro and in vivo models [129,130,131,132,133]. Here, IGF1 is linked to central nervous system cancer.